Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7149)	3/6/1999 7:47:00 AM
From: BigKNY3	Respond to of 9523

Viagra won't hit shelves for weeks --- Demand worries drug manufacturer Leslie Papp 03/06/99 The Toronto Star News of Viagra 's imminent approval has raised the hope of thousands of eager men, but they'll still have to wait, probably until next month, before getting their hands on the little blue anti-impotence pill. Pent-up Canadian demand for the wildly popular drug has Viagra 's maker worried about a stampede on pharmacies as soon as federal approval is announced - perhaps within days. "There is probably quite a number of men who already have Viagra prescriptions in their hands," says Don Sancton, spokesperson for Pfizer Canada Inc. "And we've got to make it clear to people that it will be a few weeks, after approval, before the product is actually on pharmacy shelves." Viagra has cleared Health Canada's medical and clinical review process and its final approval is now certain. The drug is in the last stage of the approval process, when federal regulators determine the exact wording on the product's label and assign it a drug identification number, essential to import the pill from its manufacturing site in France. "There are a number of production processes that can't take place until we get approval - we can't even print labels and package the product, let alone actually distribute it across the country," Sancton said. "You can't physically get product on pharmacy shelves until several weeks after approval. That's a key thing to get across to people so they don't go running out the next day to their neighbourhood pharmacy." It's estimated that up to three million Canadian men suffer from sexual dysfunction. A new Viagra study carries disappointing news for women. "We found that there was no significant change either in intercourse satisfaction or in the degree of sexual desire after the patients had taken Viagra for 12 weeks," said Dr. Steven Kaplan, a urologist at the Columbia Presbyterian Center in New York, where the study was conducted.

To: BigKNY3 who wrote (7149)	3/6/1999 7:49:00 AM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Brave Spokesman 03/06/99 The Washington Post FINAL Page A19 For Tony Kornheiser to put the worst possible face upon Bob Dole's being courageous enough to speak out about one of the cruelest side effects of prostate cancer shows just how little Kornheiser knows of the pain and embarrassment of erectile dysfunction ["Down, Bob, Down," Style, Feb. 28]. Should we tell people with a limb amputated to shut up and quit whining? Or how about telling women with breast cancer we are tired of their constant grief over losing a breast? Erectile dysfunction is a major loss to both the man who suffers from it and his wife. First, they have to expend every bit of energy they can summon to fight the cancer, and then they are left to face the loss of their sexuality. Sure, Bob Dole is being paid to advertise Viagra by Pfizer, but does this in any way lessen the courage it takes him, or any other man for that matter, to come forward and talk about this secret but very common side effect of treating prostate cancer? -- Pat Humphries Russell